Incorporating the prostate volume into predictive nomograms, alongside PSA levels, MRI findings, and other clinical parameters, can improve diagnostic accuracy, reduce unnecessary biopsies, and limit the overdiagnosis of indolent cancers. Here, KLK3 is linked to cancer.